ロード中...

Update on PD-1/PD-L1 Inhibitors in Multiple Myeloma

The treatment of cancer, especially of various types of solid tumors, has been revolutionized by the blockade of the PD-1/PD-L1 pathway by immune checkpoint inhibitors. Their success amongst hematologic malignancies, however, has been limited so far to the treatment of classic Hodgkin's lymphom...

詳細記述

保存先:
書誌詳細
出版年:Front Immunol
主要な著者: Jelinek, Tomas, Paiva, Bruno, Hajek, Roman
フォーマット: Artigo
言語:Inglês
出版事項: Frontiers Media S.A. 2018
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6250817/
https://ncbi.nlm.nih.gov/pubmed/30505301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.02431
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!